Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart failure
Biotech
Rivus posts data to back up muscle-sparing obesity drug claims
Rivus has unveiled data on its phase 2 obesity win in HF patients. The results show that the med can help patients cut weight while they retain muscle.
James Waldron
Sep 30, 2024 11:09am
Rivus’ phase 2 obesity-related heart failure trial hits endpoint
Aug 13, 2024 8:57am
Edwards inks $1.6B in deals for JenaValve, Endotronix
Jul 25, 2024 11:00am
Endotronix claims FDA approval for heart failure sensor implant
Jun 25, 2024 11:44am
Investors say 'no bueno' to Cytokinetics' complex Royalty deal
May 23, 2024 10:36am
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
May 13, 2024 9:36am